N@N

Market Maker Surveillance Report. ELRFF, SLV, CLWR, SFIO, MRK, AMGN, Bullishly Biased Price Friction For Friday, May 13th 2011

^{Published on 2011-05-13 17:50:17 - WOPRAI}
 

May 13, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 2669 companies with "abnormal" market making, 1486 companies with positive Friction Factors and 3488 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. EASTERN PLATINUM LTD (OTC:ELRFF), ISHARES SILVER TRUST (NYSE:SLV), CLEARWIRE CORP-CLASS A (NASDAQ:CLWR), SMOKEFREE INNOTEC INC (OTC:SFIO), MERCK & CO. INC. (NYSE:MRK), AMGEN INC (NASDAQ:AMGN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     ELRFF      $0.013       1.35%        82,000          7.69%        984,900         92.31%       -902,900        Abnormal
     SLV        $0.980       2.94%        28,381,103      24.13%       30,591,145      26.00%       -2,210,042      Abnormal
     CLWR       $0.020       0.50%        2,783,658       44.09%       3,532,015       55.94%       -748,357        Abnormal
     SFIO       $0.012       20.60%       71,309,335      45.73%       75,269,082      48.27%       -3,959,747      Abnormal
     MRK        $0.140       0.38%        3,193,572       27.72%       4,621,593       40.12%       -1,428,021      Abnormal
     AMGN       $0.810       1.36%        4,243,470       44.99%       5,047,773       53.51%       -804,303        Abnormal

For example, the chart above shows ELRFF with 902,900 greater shares of selling than buying (NetVol) and the stock price was up $0.01260. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

EASTERN PLATINUM LTD (OTC:ELRFF) - Eastern Platinum Limited engages in the acquisition, exploration, development, and production of platinum group metal deposits in South Africa. The company holds 87.5% interests in the Crocodile River Mine located on the western limb of the Bushveld Complex; and the Kennedys Vale project located on the eastern limb of the Bushveld Complex. It also has a 75.5% interest in the Mareesburg project located on the southern part of the eastern limb of the Bushveld Complex; and a 93.4% interest in the Spitzkop PGM project located on the eastern limb of the Bushveld Complex. The company was founded in 1989 and is headquartered in Vancouver, Canada.

ISHARES SILVER TRUST (NYSE:SLV) - ISHARES SILVER TRUST

CLEARWIRE CORP-CLASS A (NASDAQ:CLWR) - Clearwire Corporation, through its subsidiaries, builds and operates mobile broadband networks that provide high-speed residential and mobile Internet access services and residential voice services in communities in the United States. It offers wireless broadband and mobile broadband services, as well as voice over Internet protocol telephony services for homes and offices. The company also leases residential modems, as well as sells modems and personal computer cards. As of December 31, 2009, the company operated in 61 markets in the United States and Europe, covering an estimated 44.7 million people, and had approximately 642,000 retail and 46,000 wholesale subscribers. It markets its products and services directly to consumers, as well as through cellular retailers, consumer electronics stores, satellite television dealers, and computer sales and repair stores. Clearwire Corporation also markets its products and services through company-operated retail outlets. The company, formerly known as WiMAX Operations of Sprint Nextel Corporation, is headquartered in Kirkland, Washington. Clearwire Corporation operates as a subsidiary of Sprint HoldCo, LLC.

SMOKEFREE INNOTEC INC (OTC:SFIO) - Smokefree Innotec, Inc., a development stage company, engages in the design, development, manufacture, and marketing of smokeless nicotine delivery cigarettes. Its cigarettes are electronic devices that are smoke-free and tobacco-free. The company was formerly known as Courtside Products, Inc. and changed its name to Smokefree Innotec, Inc. in December 2008. Smokefree Innotec, Inc. is headquartered in Nashville, Tennessee.

MERCK & CO. INC. (NYSE:MRK) - Merck & Co., Inc., a global health care company, discovers, develops, manufactures, and markets medicines, vaccines, biologic therapies, and consumer and animal products. The companys Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular diseases, diabetes and obesity, infectious diseases, hypertension and/or heart failure, urology, bronchospasm, neurosciences and ophthalmology, oncology, and womens health; and human health vaccines, including preventative pediatric, adolescent, and adult vaccines against measles, mumps, rubella, and varicella. Merck & Co.s Animal Health segment offers antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fishes. The companys Consumer Health Care segment provides over-the-counter products, including antihistamines, products for constipation, cold/flu medicines, nasal decongestant sprays, and laxative tablets; foot care products, which comprise topical antifungal products, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, dry oils, and lip-protection products, as well as sunless tanning and sunburn relief products. It sells consumer health care products through wholesale and retail drug, food chain, and mass merchandiser outlets in the United States and Canada. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, and animal producers, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Merck & Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

AMGEN INC (NASDAQ:AMGN) - Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and delivers human therapeutics based on advances in cellular and molecular biology primarily in the United States, Europe, and Canada. The company markets primarily recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN, which selectively stimulate the production of neutrophils, a type of white blood cell that helps the body fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the bodys response to inflammatory diseases. The company also markets other products, including Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a human monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, its lead product in mid-to-late stage development include Denosumab, a human monoclonal antibody that targets a ligand, known as RANKL, an essential regulator of osteoclasts, which is under regulatory review. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net